Author:
Louis Thomas,Lucia François,Cousin François,Mievis Carole,Jansen Nicolas,Duysinx Bernard,Le Pennec Romain,Visvikis Dimitris,Nebbache Malik,Rehn Martin,Hamya Mohamed,Geier Margaux,Salaun Pierre-Yves,Schick Ulrike,Hatt Mathieu,Coucke Philippe,Lovinfosse Pierre,Hustinx Roland
Abstract
AbstractThe primary objective of the present study was to identify a subset of radiomic features extracted from primary tumor imaged by computed tomography of early-stage non-small cell lung cancer patients, which remain unaffected by variations in segmentation quality and in computed tomography image acquisition protocol. The robustness of these features to segmentation variations was assessed by analyzing the correlation of feature values extracted from lesion volumes delineated by two annotators. The robustness to variations in acquisition protocol was evaluated by examining the correlation of features extracted from high-dose and low-dose computed tomography scans, both of which were acquired for each patient as part of the stereotactic body radiotherapy planning process. Among 106 radiomic features considered, 21 were identified as robust. An analysis including univariate and multivariate assessments was subsequently conducted to estimate the predictive performance of these robust features on the outcome of early-stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. The univariate predictive analysis revealed that robust features demonstrated superior predictive potential compared to non-robust features. The multivariate analysis indicated that linear regression models built with robust features displayed greater generalization capabilities by outperforming other models in predicting the outcomes of an external validation dataset.
Publisher
Springer Science and Business Media LLC